Tenet Healthcare (THC)
(Delayed Data from NYSE)
$158.09 USD
-3.19 (-1.98%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $157.93 -0.16 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
THC 158.09 -3.19(-1.98%)
Will THC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for THC
3 Medical Stocks to Consider as Markets Take a Breather
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
THC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
Other News for THC
RSP: S&P 500 Monthly Dashboard For August
Decoding Tenet Healthcare Corp (THC): A Strategic SWOT Insight
Franklin Income SMA Q2 2025 Commentary
Franklin Income Fund Q2 2025 Commentary
What Does the Market Think About Tenet Healthcare?